Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Phathom Pharmaceuticals.

Advances In™ Overcoming Barriers to Diagnosis and Treatment of Helicobacter pylori Infections

Release Date: November 12, 2021
Expiration Date: November 12, 2022

Activity Overview

This online educational activity is designed to provide expert perspectives on the treatment of Helicobacter pylori infection, with a forward-looking perspective on how the use of novel agents may impact clinical practice. The essentials of diagnosis and first-line and refractory treatment of H pylori infection will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Phathom Pharmaceuticals.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed primarily toward primary care providers, including advanced care practitioners (eg, nurse practitioners and physician assistants) and nurses. Gastroenterologists and other clinicians involved in the management of patients with H pylori infection are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Identify appropriate patients who should undergo testing for H. pylori infection.
  • Describe strategies to overcome current challenges to the successful eradication of H. pylori infection.
  • Apply evidence and patients' medical history, including antibiotic use, to the selection of appropriate therapies for H. pylori infection.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.


Edward Manno, MD, MS
Colin W. Howden, MD, FRCP (Glasg.), FACP, AGAF, FACG, FCP
Professor Emeritus
University of Tennessee College of Medicine
Memphis, TN

Disclosures: Consultant: Phathom Pharmaceuticals, RedHill Biopharma, Ironwood Pharmaceuticals, Allakos, Alfasigma Pharmaceuticals, Clexio Biosciences. Speaker’s Bureau: Alnylam, RedHill Biopharma. Stock/Shareholder: Antibe Therapeutics.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By